Tenet Healthcare Corporation

THC Healthcare Medical Care Facilities

In the quarter to June 2026, revenue grew 14.6%, EPS grew 213.0%, free cash flow fell 43.9% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years.

268.62 6.51 −2.37%
Market cap
$22.2B
P/E
10.3×
Fwd P/E
6.4×
Dividend yield
—
F-score
7/9
Altman Z
1.91
Beneish M
−2.67
Dividend safety
57/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
12.73 3.88 12.63 12.76 9.58 10.54 0.00 15.72 0.00 0.00
Piotroski F-Score
7 7 9 4 7 6 5 6 3 5
P/S ratio
0.84 0.59 0.38 0.27 0.45 0.24 0.21 0.10 0.08 0.08
Altman Z-Score
1.91 2.00 1.29 1.14 1.28 0.98 1.01 1.01 0.94 0.96
Altman Z″-Score (non-manufacturers)
2.29 2.75 1.26 0.95 1.11 0.83 0.36 0.43 0.36 0.48
P/FCF ratio
7.08 10.96 4.76 16.32 9.59 1.46 6.98 4.05 3.26 0.00
Beneish M-Score
(2.67) (2.25) (2.69) (2.39) (2.48) (2.92) (2.64) (2.59) (2.89) (2.48)
P/Operating CF
24.51 (36.96) 9.38 12.44 24.45 9.40 7.56 7.00 3.28 (5.22)
Dividend Safety Score
57 — — — — — — — — —
P/B ratio
2.98 2.10 2.48 2.13 4.25 4.48 9.00 2.55 2.98 1.41
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
1.32 1.08 1.05 1.01 1.13 0.99 1.00 0.88 0.83 0.82
EV/EBITDA
6.42 3.29 6.30 6.07 5.86 6.06 7.61 6.51 7.86 7.52
EV/Operating CF
7.97 10.94 9.06 17.97 14.04 5.13 14.94 15.41 13.28 28.80
EV/FCF
11.15 20.06 13.25 60.62 24.19 6.09 32.72 37.42 32.32 (50.69)
Quick Ratio
1.22 1.29 0.87 0.85 1.00 1.06 0.72 0.78 0.75 0.90
Current Ratio
1.76 1.78 1.51 1.34 1.38 1.47 1.21 1.20 1.29 1.30
Net Debt/EBITDA
2.34 1.49 4.04 4.43 3.53 4.60 5.98 5.80 7.07 6.80
Debt/Assets
44.38% 45.52% 52.99% 55.53% 56.73% 57.99% 63.13% 66.16% 63.87% 61.76%
Debt/Equity
2.19 2.26 4.81 6.13 7.62 16.78 33.76 21.58 27.71 14.10
Asset Turnover
0.73 0.72 0.74 0.70 0.71 0.70 0.81 0.80 0.80 0.81
Operating CF/Net income
2.52 0.64 3.89 2.64 1.72 8.54 (5.73) 10.09 (1.70) (2.91)
Capex/Depreciation
(1.14) (1.10) (0.83) (0.87) (0.74) (0.60) (0.76) (0.73) (0.77) (0.98)
Interest Coverage
4.27 7.21 2.79 2.62 3.11 1.98 1.56 1.63 1.08 1.27
ROE
23.77% 71.61% 21.92% 18.21% 61.12% 58.08% (38.26%) 16.97% (86.86%) (18.82%)
ROA
4.80% 11.18% 2.20% 1.50% 3.34% 1.58% (0.94%) 0.45% (2.93%) (0.79%)
ROIC
13.45% 23.30% 9.29% 8.74% 11.70% 8.75% 6.44% 6.77% 4.68% 4.99%
Return on Tangible Assets
14.50% 33.97% 7.07% 5.16% 10.89% 4.44% (2.77%) 1.34% (8.51%) (2.07%)
Average Days of Receivables
43.93 44.77 51.72 56.02 51.89 55.66 54.38 52.14 49.88 53.97
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.42 0.42 0.41 0.43 0.39 0.38 0.38 0.40 0.38 0.38
Share Based Compensation of Revenue
0.49% 0.32% 0.32% 0.29% 0.29% 0.25% 0.23% 0.25% 0.31% 0.35%
Graham Net Nets
(0.88) (1.26) (2.33) (3.57) (2.11) (4.54) (4.54) (9.76) (10.74) (12.00)
Graham Number
153.11 209.66 64.45 44.57 60.75 27.58 0.00 12.85 0.00 0.00
Earnings Yield
7.86% 25.77% 7.92% 7.84% 10.44% 9.49% (5.86%) 6.36% (43.71%) (12.53%)
Free Cash Flow Yield
14.12% 9.12% 21.00% 6.13% 10.43% 68.38% 14.32% 24.68% 30.65% (20.73%)
Revenue per Share
236.38 213.36 202.32 179.32 182.39 167.98 178.72 179.35 190.66 197.55
Operating CF per Share
39.27 21.12 23.36 10.13 14.68 32.44 11.92 10.27 11.93 5.62
Capex per Share
(11.20) (9.61) (7.39) (7.13) (6.16) (5.14) (6.48) (6.04) (7.03) (8.81)
Free Cash Flow per Share
28.06 11.52 15.97 3.00 8.52 27.30 5.45 4.23 4.90 (3.19)
Cash per Share
31.98 31.15 12.08 8.02 22.13 23.29 2.53 4.03 6.07 7.21
Shareholders Equity per Share
66.74 60.06 30.67 23.00 19.23 8.92 4.23 6.73 5.36 10.89
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
66.74 60.06 30.67 23.00 19.23 8.92 4.23 6.73 5.36 10.89
Free Cash Flow
2,530.00 1,116.00 1,623.00 321.00 910.00 2,867.00 563.00 432.00 493.00 (317.00)
Working Capital
3,386.00 3,372.00 2,407.00 1,505.00 1,966.00 2,300.00 876.00 779.00 1,241.00 1,223.00
Capital Expenditures
(1,010.00) (931.00) (751.00) (762.00) (658.00) (540.00) (670.00) (617.00) (707.00) (875.00)
Net Current Asset Value
(15,811.00) (15,434.00) (18,028.00) (18,716.00) (18,450.00) (19,022.00) (17,847.00) (17,086.00) (17,273.00) (18,362.00)
EV/EBIT
8.04 3.76 8.57 8.34 7.67 8.78 11.99 9.87 14.32 12.89
Capex to Sales
0.05 0.05 0.04 0.04 0.03 0.03 0.04 0.03 0.04 0.04
Price to Operating Income
5.11 2.05 3.08 2.24 3.04 2.11 2.56 1.07 1.45 1.23
Other line items
Depreciation/Fixed assets
0.14 0.14 0.14 0.14 0.14 0.13 0.13 0.12 0.13 0.11
Cash ROIC
11.46% 5.07% 8.39% 1.74% 4.54% 15.01% 3.64% 2.71% 3.06% (1.86%)
Accounts Receivable Turnover
8.36 7.59 7.02 6.71 7.14 6.48 6.88 6.99 6.95 6.99
Accounts Payable Turnover
9.41 9.21 8.75 8.64 9.74 9.46 9.75 9.77 9.87 9.19
Inventory Turnover
35.98 32.89 31.22 30.71 32.46 33.63 38.23 39.18 40.19 39.22
Average Days of Payables
39.76 37.94 40.35 45.30 38.87 38.65 37.38 37.86 34.70 38.96
Days of Inventory on Hand
10.17 10.15 11.78 12.20 11.48 11.78 9.63 9.57 8.54 9.56
Average Receivables
2,550.50 2,725.00 2,928.50 2,856.50 2,730.00 2,721.50 2,684.50 2,618.50 2,761.00 2,806.00
Average Payables
1,327.00 1,351.00 1,456.00 1,402.00 1,253.50 1,205.50 1,205.50 1,191.00 1,252.00 1,354.50
Average Inventory
347.00 378.50 408.00 394.50 376.00 339.00 307.50 297.00 307.50 317.50
Average Assets
29,306.50 28,624.00 27,734.00 27,367.50 27,342.50 25,235.50 22,887.00 22,897.00 24,043.00 24,191.50
Average Common Equity
5,918.50 4,468.50 2,788.00 2,256.50 1,495.50 687.00 562.00 613.00 810.50 1,020.00

Fold the line items

Columns are period end dates